Cite

    Klemens Budde et al.. “Pharmacokinetics and pharmacodynamics of everolimus in patients with renal angiomyolipoma and tuberous sclerosis complex or lymphangioleiomyomatosis.” British journal of clinical pharmacology, vol. 81, n.d., pp. 958–970. http://access.bl.uk/ark:/81055/vdc_100031988189.0x000026